Today: 11 April 2026
Subscribe
Browse Category

NYSE:ANVS 17 November 2025

Annovis Bio (ANVS) Soars After New Parkinson’s Biomarker Data Show Buntanetap Halts Cognitive Decline – November 17, 2025

Annovis Bio (ANVS) Soars After New Parkinson’s Biomarker Data Show Buntanetap Halts Cognitive Decline – November 17, 2025

Annovis Bio reported new Phase 3 data showing its drug buntanetap halted cognitive decline in early Parkinson’s patients and improved Alzheimer’s-related biomarkers in a key subgroup with amyloid co-pathology. Shares of ANVS surged following the announcement. The company plans to present full biomarker results at the CTAD 2025 conference in December.
17 November 2025
·

Stock Market Today

  • 3 UK Value Stocks Poised for 66%+ Gains by 2026 for ISA Investors
    April 11, 2026, 7:54 AM EDT. Amid volatile markets and shifting sectors, three UK value stocks show strong potential for ISA portfolios in 2026. Barratt Redrow, a housebuilder, has a 66% forecasted price rise supported by rising revenues and a 7% dividend yield though sensitive to interest rate risks. Burford Capital, in legal finance, leads with a projected 107% increase based on profitability metrics and solid FY25 results, yet investment risks persist due to case-dependent returns. GB Group, a smaller tech firm, holds an 82% target rise backed by recent earnings growth and a share buyback extension, but bears higher volatility and a high P/E of 57. Analysts widely rate all three as Strong Buys, despite inherent sector and company-specific uncertainties.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 11.04.2026

11 April 2026
LIVEMarkets rolling coverageStarted: April 11, 2026, 12:00 AM EDTUpdated: April 11, 2026, 8:03 AM EDT 3 UK Value Stocks Poised for 66%+ Gains by 2026 for ISA Investors April 11, 2026, 7:54 AM EDT. Amid volatile markets and shifting sectors, three UK value stocks show strong potential for ISA portfolios in 2026. Barratt Redrow, a housebuilder, has a 66% forecasted price rise supported by rising revenues and a 7% dividend yield though sensitive to interest rate risks. Burford Capital, in legal finance, leads with a projected 107% increase based on profitability metrics and solid FY25 results, yet investment risks persist
UK Stock Market Today: FTSE 100 Climbs as Traders Eye Fragile Iran Ceasefire

UK Stock Market Today: FTSE 100 Climbs as Traders Eye Fragile Iran Ceasefire

10 April 2026
London’s FTSE 100 rose 0.38% to 10,644.28 late Friday morning as investors awaited U.S.-Iran talks in Pakistan. Brent crude climbed 1% to $96.83 a barrel, while sterling eased but was on track for its biggest weekly gain since January. The FTSE 250 gained 0.79%. Britain’s 10-year gilt yield stood at 4.807%.
US Stock Market Today: CPI, Oil and Iran Truce Set the Tone Before the Open

US Stock Market Today: CPI, Oil and Iran Truce Set the Tone Before the Open

10 April 2026
Dow e-minis slipped 0.15% before Friday’s open, with S&P 500 and Nasdaq 100 futures each down 0.08% as traders awaited March CPI data and watched U.S.-Iran tensions. Economists expect headline CPI to rise 0.9% for March and 3.3% year-on-year. Weekly jobless claims increased to 219,000. Brent crude traded near $97 a barrel, while shipping through the Strait of Hormuz remained well below normal.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 10.04.2026

10 April 2026
LIVEMarkets rolling coverageStarted: April 10, 2026, 12:00 AM EDTUpdated: April 10, 2026, 11:59 PM EDT Orora ASX:ORA Faces Earnings Reset After Saverglass Impact and Middle East Disruptions April 10, 2026, 11:59 PM EDT. Orora (ASX:ORA) shares plunged over 8% in one day following a guidance update that revealed an earnings reset at its Saverglass unit due to Middle East supply chain disruptions and a shutdown at the Ras Al Khaimah glass plant. Despite a sharp short-term loss, Orora's 90-day share price rise exceeds 33%, contrasting a longer-term 10.58% annual total shareholder return decline amid ongoing sector pressures. Trading at A$1.49,
Go toTop